EYPT
Eyepoint Pharmaceuticals Inc
NASDAQ: EYPT · HEALTHCARE · BIOTECHNOLOGY
$13.20
+2.64% today
Updated 2026-04-30
Market cap
$1.08B
P/E ratio
—
P/S ratio
34.35x
EPS (TTM)
$-3.17
Dividend yield
—
52W range
$5 – $19
Volume
1.2M
Eyepoint Pharmaceuticals Inc (EYPT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.47M | $2.23M | $3.48M | $12.16M | $23.05M | $4.96M | $3.53M | $2.14M | $3.47M | $26.57M | $1.62M | $7.54M | $2.96M | $20.36M | $34.44M | $36.94M | $41.40M | $46.02M | $43.27M | $31.37M |
| Revenue growth (YoY) | — | +52.5% | +55.5% | +249.9% | +89.5% | -78.5% | -29.0% | -39.2% | +62.1% | +664.9% | -93.9% | +365.4% | -60.7% | +587.8% | +69.1% | +7.3% | +12.1% | +11.1% | -6.0% | -27.5% |
| Cost of revenue | $24.32M | $24.09M | $13.36M | $10.64M | $11.61M | $7.04M | $7.00M | $9.57M | $78000.00 | $14.38M | $14.88M | $16.18M | $18.50M | $2.69M | $5.82M | $8.18M | $8.33M | $4.63M | $3.71M | $2.07M |
| Gross profit | $1.47M | $2.23M | $3.48M | $12.16M | $23.05M | $-2.07M | $-3.48M | $-7.43M | $3.40M | $26.57M | $1.62M | $7.54M | $-15.54M | $17.68M | $28.61M | $28.76M | $33.08M | $41.39M | $39.56M | $29.30M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -41.8% | -98.7% | -346.7% | 97.8% | 100.0% | 100.0% | 100.0% | -524.9% | 86.8% | 83.1% | 77.9% | 79.9% | 89.9% | 91.4% | 93.4% |
| R&D | $11.70M | $20.03M | $14.43M | $8.01M | $6.99M | $6.86M | $7.04M | $7.00M | $9.57M | $12.09M | $14.38M | $14.88M | $16.18M | $15.37M | $17.42M | $28.50M | $49.64M | $64.66M | $132.93M | $221.04M |
| SG&A | — | $13.95M | $13.95M | $8.79M | $6.97M | $8.10M | $6.87M | $7.17M | $7.47M | $8.06M | $9.01M | $11.23M | $11.54M | $17.94M | $20.73M | $25.57M | $34.82M | $40.10M | $52.36M | $51.61M |
| Operating income | $-27.68M | $-35.54M | $-24.90M | $-4.64M | $9.09M | $-10.00M | $-25.21M | $-12.03M | $-13.49M | $6.42M | $-21.77M | $-18.58M | $-26.27M | $-47.86M | $-37.29M | $-55.28M | $-99.64M | $-75.07M | $-145.85M | $-243.43M |
| Operating margin | -1888.6% | -1590.2% | -716.4% | -38.1% | 39.4% | -201.5% | -715.0% | -561.4% | -388.4% | 24.2% | -1344.1% | -246.4% | -887.3% | -235.0% | -108.3% | -149.6% | -240.6% | -163.1% | -337.1% | -776.0% |
| EBITDA | $-22.05M | $-75.65M | $-24000.00 | $9.09M | $-5.49M | $-22.78M | $-11.04M | $-12.65M | $7.30M | $7.30M | $-20.87M | $-17.76M | $-36.99M | $-48.01M | $-35.49M | $-50.15M | $-96.62M | $-69.00M | $-129.23M | $-243.43M |
| EBITDA margin | -1504.4% | -3384.6% | -0.7% | 74.7% | -23.8% | -458.8% | -313.0% | -590.3% | 210.3% | 27.5% | -1288.0% | -235.6% | -1249.4% | -235.8% | -103.1% | -135.8% | -233.4% | -149.9% | -298.6% | -776.0% |
| EBIT | $-30.74M | $-84.36M | $-421000.00 | $5.65M | $-8.82M | $-26.13M | $-13.26M | $-13.64M | $6.39M | $6.42M | $-21.77M | $-18.58M | $-39.65M | $-50.62M | $-38.14M | $-52.92M | $-99.06M | $-69.47M | $-130.77M | — |
| Interest expense | $3.37M | $1.94M | $507000.00 | $0.00 | $13000.00 | $1000.00 | $0.00 | $2000.00 | $1000.00 | $0.00 | $0.00 | $720000.00 | $720000.00 | $6.18M | $7.26M | $5.50M | $3.19M | $1.25M | $14000.00 | $33000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-20.91M | $-103.67M | $-75.67M | $-2.51M | $8.75M | $-8.63M | $-24.84M | $-11.90M | $-13.36M | $6.35M | $-21.55M | $-18.48M | $-53.17M | $-56.79M | $-45.39M | $-58.42M | $-102.25M | $-70.80M | $-130.87M | $-231.96M |
| Net income growth (YoY) | — | -395.7% | +27.0% | +96.7% | +448.6% | -198.6% | -187.8% | +52.1% | -12.2% | +147.5% | -439.5% | +14.2% | -187.6% | -6.8% | +20.1% | -28.7% | -75.0% | +30.8% | -84.9% | -77.2% |
| Profit margin | -1427.1% | -4638.7% | -2176.9% | -20.6% | 38.0% | -173.8% | -704.3% | -555.3% | -384.5% | 23.9% | -1330.1% | -245.2% | -1795.7% | -278.9% | -131.8% | -158.1% | -247.0% | -153.8% | -302.4% | -739.4% |